Veru Announces Safety and Body Composition Data from Two Late-Breaker Presentations at the American Diabetes Association’s 84th Scientific Sessions

Florida News

MIAMI, FL, June 24, 2024 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced data from two late-breaker presentations at the American

Read More